Thrombomodulin-dependent effect of factor V Leiden mutation on factor XIII activation

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages 508-513

  Koncz, Zsuzsa ^a   Bagoly, Zsuzsa ^a   Haramura, Gizella ^a   Mezei, Zoltán A ^a   Muszbek, László ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

factor V Leiden mutation; factor XIII; fibrin; thrombomodulin

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRIN; PHOSPHOLIPID; RECOMBINANT THROMBOMODULIN; THROMBOMODULIN; THROMBOPLASTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; DIMERIZATION; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IN VIVO STUDY; MALE; MUTATION; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING; WILD TYPE;

ADULT; AGED; COMPLEMENT ACTIVATION; DOWN-REGULATION; FACTOR V; FACTOR XIII; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTEIN BINDING; THROMBOMODULIN; YOUNG ADULT;

EID: 84858336194     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.06.030     Document Type: Article

References (38)

1. B. Dahlback Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism Blood 85 1995 607 614
2. F.R. Rosendaal Venous thrombosis: a multicausal disease Lancet 353 1999 1167 1173
3. R.M. Bertina, B.P. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, and H. de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
4. K. Segers, B. Dahlback, and G.A. Nicolaes Coagulation factor V and thrombophilia: background and mechanisms Thromb Haemost 98 2007 530 542
5. B. Dahlback Advances in understanding pathogenic mechanisms of thrombophilic disorders Blood 112 2008 19 27
6. E. Thorelli, R.J. Kaufman, and B. Dahlback Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V Blood 93 1999 2552 2558
7. E. Castoldi, J.M. Brugge, G.A. Nicolaes, D. Girelli, G. Tans, and J. Rosing Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations Blood 103 2004 4173 4179
8. C. van 't Veer, M. Kalafatis, R.M. Bertina, P. Simioni, and K.G. Mann Increased tissue factor-initiated prothrombin activation as a result of the Arg506 - > Gln mutation in factor VLEIDEN J Biol Chem 272 1997 20721 20729
9. L. Bajzar, M. Kalafatis, P. Simioni, and P.B. Tracy An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden J Biol Chem 271 1996 22949 22952
10. L.O. Mosnier, J.C. Meijers, and B.N. Bouma Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin Thromb Haemost 85 2001 5 11
11. L. Muszbek, Z. Bagoly, Z. Bereczky, and E. Katona The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis Cardiovasc Hematol Agents Med Chem 6 2008 190 205
12. C.S. Greenberg, and M.A. Shuman The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen J Biol Chem 257 1982 6096 6101
13. I. Komaromi, Z. Bagoly, and L. Muszbek Factor XIII: novel structural and functional aspects J Thromb Haemost. 9 2011 9 20
14. A.H. Shemirani, G. Haramura, Z. Bagoly, and L. Muszbek The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma Biochim Biophys Acta 1764 2006 1420 1423
15. K.E. Achyuthan, T.C. Rowland, P.J. Birckbichler, K.N. Lee, P.D. Bishop, and A.M. Achyuthan Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin Mol Cell Biochem 162 1996 43 49
16. K.N. Lee, K.W. Jackson, V.J. Christiansen, K.H. Chung, and P.A. McKee A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion Blood 103 2004 3783 3788
17. K. Bangert, A.H. Johnsen, U. Christensen, and S. Thorsen Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma Biochem J 291 Pt 2 1993 623 625
18. Y. Sumi, Y. Ichikawa, Y. Nakamura, O. Miura, and N. Aoki Expression and characterization of pro alpha 2-plasmin inhibitor J Biochem 106 1989 703 707
19. Y. Sakata, and N. Aoki Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis J Clin Invest 69 1982 536 542
20. I. Balogh, G. Szoke, L. Karpati, U. Wartiovaara, E. Katona, and I. Komaromi Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia Blood 96 2000 2479 2486
21. R.A. Ariens, H. Philippou, C. Nagaswami, J.W. Weisel, D.A. Lane, and P.J. Grant The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood 96 2000 988 995
22. B.P. Koeleman, P.H. Reitsma, C.F. Allaart, and R.M. Bertina Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families Blood 84 1994 1031 1035
23. A.H. Shemirani, and L. Muszbek Rapid detection of the factor XIII Val34Leu (163 G- > T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis Clin Chem Lab Med 42 2004 877 879
24. K.E. Brummel, S. Butenas, and K.G. Mann An integrated study of fibrinogen during blood coagulation J Biol Chem 274 1999 22862 22870
25. B. Dahlback Human coagluation factor V purification and thrombin-catalyzed activation J Clin Invest 66 1980 583 591
26. A.W. Dielis, W.M. Balliel, R. van Oerle, W.T. Hermens, H.M. Spronk, and H. Ten Cate Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A Haematologica 93 2008 1351 1357
27. J. Polgar, I. Lerant, L. Muszbek, and R. Machovich Thrombomodulin inhibits the activation of factor XIII by thrombin Thromb Res 43 1986 685 690
28. C.S. Greenberg, and C.C. Miraglia The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation Blood 66 1985 466 469
29. S.D. Lewis, T.J. Janus, L. Lorand, and J.A. Shafer Regulation of formation of factor XIIIa by its fibrin substrates Biochemistry 24 1985 6772 6777
30. C.S. Greenberg, K.E. Achyuthan, S. Rajagopalan, and S.V. Pizzo Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII Arch Biochem Biophys 262 1988 142 148
31. M.C. Naski, L. Lorand, and J.A. Shafer Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII Biochemistry 30 1991 934 941
32. T.J. Janus, S.D. Lewis, L. Lorand, and J.A. Shafer Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen Biochemistry 22 1983 6269 6272
33. T.J. Hornyak, and J.A. Shafer Interactions of factor XIII with fibrin as substrate and cofactor Biochemistry 31 1992 423 429
34. H. Philippou, J. Rance, T. Myles, S.W. Hall, R.A. Ariens, and P.J. Grant Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate J Biol Chem 278 2003 32020 32026
35. A.C. Parker, L.V. Mundada, A.H. Schmaier, and W.P. Fay Factor VLeiden inhibits fibrinolysis in vivo Circulation 110 2004 3594 3598
36. L.O. Mosnier, and B.N. Bouma Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis Arterioscler Thromb Vasc Biol 26 2006 2445 2453
37. L.O. Mosnier, J.C. Meijers, and B.N. Bouma The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis Thromb Haemost 86 2001 1040 1046
38. L.O. Mosnier, M.G. Elisen, B.N. Bouma, and J.C. Meijers Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation Thromb Haemost 86 2001 1057 1064